Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stacey Tuey"'
Autor:
Stacey Tuey, Melanie S. Joy, Mustafa E Ibrahim, Uma Fogueri, Indushekhar Persaud, Jared M. Brown, Gavriel Roda, Thomas J. Anchordoquy, Georgia Charkoftaki, Joshua M. Thurman, Michael F. Wempe
Publikováno v:
Drug Delivery and Translational Research. 12:1445-1454
Studies have suggested imatinib mesylate (ImM) as a potential treatment for systemic lupus erythematosus nephritis (SLEN). However, ImM has limited renal excretion. The goal of the current research was to develop an ImM containing nanoformulation, co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e2c7fd8bb25b064695fe2c444b6b205
https://doi.org/10.1007/s13346-021-01022-4
https://doi.org/10.1007/s13346-021-01022-4
Autor:
Georgia Charkoftaki, Melanie S. Joy, Amandla Atilano-Roque, Joshua M. Thurman, Thomas D. Nolin, Stacey Tuey
Publikováno v:
Xenobiotica. :1-11
Effects of cholecalciferol (VitD3) and calcitriol (1,25-VitD3), on the expression and function of major vitamin D metabolizing enzymes (cytochrome P450 [CYP]2R1, CYP24A1) and select drug transport ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2077ac47254905feb72d9113cadf5f7
https://doi.org/10.1080/00498254.2021.1909783
https://doi.org/10.1080/00498254.2021.1909783
Identification of Novel Biomarkers for Predicting Kidney Injury Due to Drugs Using 'Omic' Strategies
Publikováno v:
Pharmacogenomics and Personalized Medicine. 13:687-705
Drug-induced kidney injury accounts for 20% of community- and hospital-acquired cases of acute kidney injury (AKI). The incidence is higher among older individuals, who often have co-existing morbidities and are exposed to more diagnostic procedures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a1beb4d52cc267ab936985c0f2e84fa
https://doi.org/10.2147/pgpm.s239471
https://doi.org/10.2147/pgpm.s239471
Autor:
Uma, Fogueri, Georgia, Charkoftaki, Gavriel, Roda, Stacey, Tuey, Mustafa, Ibrahim, Indushekhar, Persaud, Michael F, Wempe, Jared M, Brown, Joshua M, Thurman, Thomas J, Anchordoquy, Melanie S, Joy
Publikováno v:
Drug delivery and translational research. 12(6)
Studies have suggested imatinib mesylate (ImM) as a potential treatment for systemic lupus erythematosus nephritis (SLEN). However, ImM has limited renal excretion. The goal of the current research was to develop an ImM containing nanoformulation, co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::73d398eedd4c4beeb0a1d0df4956127f
https://pubmed.ncbi.nlm.nih.gov/34322850
https://pubmed.ncbi.nlm.nih.gov/34322850